Evidence map›Paper›PMID 40746510›Full record

ArticleOpen respiratory archives

[Risk Management in Performing Post-Pandemic Pulmonary Function Tests].

Luis Puente Maestu, Juana M Martínez Llorens, José Luis Valera Felices, Yolanda Torralba García, Marian Gimeno Peribáñez, Eusebi Chiner, Roberto Cabestre, Juan Rodríguez Hermosa, Raúl Godoy Mayoral, Celeste Marcos and 2 more

Abstract readEnglish Abstract
In one paragraph

Article in Open respiratory archives. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Luis Puente MaestuInstituto de Investigación Biomédica Gregorio Marañón-Facultad de Medicina-Universidad Complutense de Madrid, Madrid, España.
Juana M Martínez LlorensServicio de Neumología, Hospital del Mar. Barcelona, España.
José Luis Valera FelicesServicio de Neumología, Hospital Universitario de Son Espases, Palma, Islas Baleares, España.
Yolanda Torralba GarcíaServicio de Neumología, Hospital Clinic, Barcelona, España.
Marian Gimeno PeribáñezServicio de Neumología, Hospital Universitario Dr. Josep Trueta. Girona, España.
Eusebi ChinerServicio de Neumología, Hospital Sant Joan. Alicante, España.
Roberto CabestreServicio de Neumología, Hospital Royo Villanova. Zaragoza, España.
Juan Rodríguez HermosaServicio de Neumología, Hospital Universitario Clínico San Carlos. Madrid, España.
Raúl Godoy MayoralServicio de Neumología, Hospital Universitario de Albacete, Albacete, España.
Celeste MarcosServicio de Neumología, Hospital Universitario de la Princesa. Madrid, España.
Ana Balaña CorberóServicio de Neumología, Hospital del Mar. Barcelona, España.
Carlos AlmonacidServicio de Neumología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This document is a detailed proposal addressing the management of spirometry and other pulmonary function tests in the post-COVID-19 pandemic context in Spain. The introduction discusses how the pandemic has affected the performance of these essential tests and underscores the need for a pragmatic assessment of risks and benefits, given that the absence of pulmonary function studies may lead to significant diagnostic and therapeutic errors.The section on the epidemiological situation in Spain highlights that the WHO no longer considers COVID-19 a public health emergency of international concern, reflecting the reduced severity of the disease due to high vaccination coverage and the characteristics of circulating variants.The regulatory framework states that the Health Institute Carlos III has defined a new epidemiological surveillance strategy aimed at restoring social and healthcare normality. A ministerial order issued by the Ministry of Health is mentioned, which lifts the mandatory use of facemasks in certain settings, in alignment with the strategy to return to normalcy.The proposal provides an in-depth analysis of the infectious risk to healthcare workers and patients in pulmonary function laboratories, concluding that current practices -along with the use of surgical masks and viral filters- minimize the generation and transmission of infectious aerosols.Detailed recommendations are provided for risk management, including architectural controls, administrative measures, hygiene practices, and personal protective protocols, with the goal of safeguarding both healthcare professionals and patients.The cited bibliography reinforces the scientific evidence base underlying the proposed recommendations and demonstrates a careful and deliberate approach to the safe and efficient reintroduction of spirometry and other pulmonary function tests into routine healthcare.

Indexed as

COVID-19Infectious riskPulmonary function tests

Identifiers

PMID40746510
PMCPMC12311503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.